Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-01-01 @ 1:52 AM
Study NCT ID:
NCT04502433
Status:
TERMINATED
Last Update Posted:
2023-06-23
First Post:
2020-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)
Sponsor:
Chiesi Farmaceutici S.p.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-03
First Submit QC Date:
None
Study First Post Date:
2020-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-16
Results First Submit QC Date:
None
Results First Post Date:
2023-06-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-31
Last Update Post Date:
2023-06-23
Last Update Post Date Type:
ACTUAL